摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Suberinsaeure-bis-ethylamid | 91565-14-9

中文名称
——
中文别名
——
英文名称
Suberinsaeure-bis-ethylamid
英文别名
N,N'-diethyloctanediamide
Suberinsaeure-bis-ethylamid化学式
CAS
91565-14-9
化学式
C12H24N2O2
mdl
——
分子量
228.335
InChiKey
HXBVQHIRATZEJI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.3
  • 重原子数:
    16
  • 可旋转键数:
    9
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.83
  • 拓扑面积:
    58.2
  • 氢给体数:
    2
  • 氢受体数:
    2

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    Suberinsaeure-bis-ethylamid 在 lithium aluminium tetrahydride 作用下, 生成 N,N'-diethyl-octane-1,8-diamine
    参考文献:
    名称:
    The Preparation and Biological Activity of some N,N'-Bis(haloacyl)-polymethylenediamines
    摘要:
    DOI:
    10.1021/jm50016a002
点击查看最新优质反应信息

文献信息

  • GUANIDINO-SUBSTITUTED BI-AND POLYPHENYLS AS SMALL MOLECULE CARRIERS
    申请人:Selwood David
    公开号:US20120077863A1
    公开(公告)日:2012-03-29
    A compound of formula I, or a pharmaceutically acceptable salt thereof, wherein —X 1 , X 2 and X 3 are each independently where Y is an alkylene, alkenylene or alkynylene group, each of which may be optionally substituted with one or more substituents selected from alkyl, halo, CF 3 , OH, alkoxy, NH 2 , CN, NO 2 and COOH; W is absent or is O, S or NH; R 1 , R 2 , R 3 and R 4 are each independently selected from H, alkyl, aryl and a protecting group Pi; R 7 , R 8 and R 9 are each independently selected from H, alkyl, halo, CF 3 , OH, alkoxy, CN, NO 2 and COOH; —q is 1, 2, 3 or 4; q′ is 0, 1, 2 or 3, where q+q′ equals 4; p and r are each independently 1, 2, 3, 4 or 5; p′ and r′ are each independently 0, 1, 2, 3 or 4, where p+p′ and r+r′ each equal 5; and —n is 0, 1, 2, 3, 4, 5 or 6.
  • [EN] NEW COMPOUNDS<br/>[FR] NOUVEAUX COMPOSÉS
    申请人:UCL BUSINESS PLC
    公开号:WO2010097604A2
    公开(公告)日:2010-09-02
    A compound of formula I, or a pharmaceutically acceptable salt thereof, wherein - X1, X2 and X3 are each independently where Y is an alkylene, alkenylene or alkynylene group, each of which may be optionally substituted with one or more substituents selected from alkyl, halo, CF3, OH, alkoxy, NH2, CN, NO2 and COOH; W is absent or is O, S or NH; R1, R2, R3 and R4 are each independently selected from H, alkyl, aryl and a protecting group Pi; R7, R8 and R9 are each independently selected from H, alkyl, halo, CF3, OH, alkoxy, CN, NO2 and COOH; - q is 1, 2, 3 or 4; q' is 0, 1, 2 or 3, where q + q' equals 4; p and r are each independently 1, 2, 3, 4 or 5; p' and r' are each independently 0, 1, 2, 3 or 4, where p + p' and r + r' each equal 5; and - n is 0, 1, 2, 3, 4, 5 or 6.
查看更多